Gyre Therapeutics, Inc. GYRE Other Non-Current Liabilities
Other Non-Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Gyre Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherLiabilitiesNoncurrent.
The official record: Gyre Therapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Gyre Therapeutics, Inc.'s other non-current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Gyre Therapeutics, Inc.'s other non-current liabilities?
- Gyre Therapeutics, Inc. (GYRE) reported other non-current liabilities of $1.46M in Q1 2026.
- How has Gyre Therapeutics, Inc.'s other non-current liabilities changed year-over-year?
- Gyre Therapeutics, Inc.'s other non-current liabilities increased by 4.2% year-over-year, from $1.4M to $1.46M.
- What is the long-term trend for Gyre Therapeutics, Inc.'s other non-current liabilities?
- Over 3 years (2022 to 2025), Gyre Therapeutics, Inc.'s other non-current liabilities has grown at a 197.5% compound annual growth rate (CAGR), from $55K to $1.45M.
- What does other non-current liabilities mean?
- Miscellaneous long-term obligations not classified in specific categories — pension liabilities, environmental remediation, and other long-term accruals.